India Approves Oral Drug for Treating Kala-Azar

by Medindia Content Team on  November 30, 2006 at 11:16 AM Drug News
RSS Email Print This Page Comment bookmark
Font : A-A+

India Approves Oral Drug for Treating Kala-Azar
The Drug Controller General of India has recently approved oral anti Kala-azar drug "Miltefosine" for treatment of Kala-azar patients.

The clinical trials of Miltefosine - oral drug have been conducted by Indian Council of Medical Research, New Delhi. Based on the results of clinical trials, the Expert Committee of the Directorate of Health Services has recommended introduction of Miltefosine as first line of treatment.

The Government of India has already decided to introduce the drug in 10 Kala-azar endemic districts in the country and procurement of drug is under way.

This information was given in the Lok Sabha today by Smt. Panabaka Lakshmi, Minister of State in the Ministry of Health and Family Welfare in a written reply to a question by Shri Braja Kishore Tripathy.

Source: PIB
SRM

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Drug Toxicity Signature Drug Toxicity Dental Check-Up 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor
Advertisement

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive